Bristol Myers Squibb is committed to helping appropriate patients get access to our medications by providing access and reimbursement support services.

This information is intended for U.S. healthcare professionals and/or healthcare professionals involved in healthcare reimbursement.

Medication Selector >

INREBIC® (fedratinib)

Charitable Foundations
Resource

InrM
Find Local Care Resources for
Your Patients

Help patients find transportation, medical services, care at home, and other healthcare-related resources.

Formulary Large Icon Go to Patient Resource Connections
 

This site is operated by a third party and is not affiliated with Bristol Myers Squibb.

See Payer Policy Details

Learn about payer information by state for applicable treatments

Formulary Large Icon Start Here >

Billing and
Diagnosis Codes

The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.

Reimbursement and Coding Guide for INREBIC
Download

  • Codes*
  • Distribution
  • FDA Letters


Filter by keyword Clear Filter
Type a keyword to find a specific HCPCS, NDC, or ICD-10 code
Healthcare Common Procedure Coding System (HCPCS) Codes1 Issued by CMS
J8999

Prescription drug, oral, chemotherapeutic, NOS

National Drug Codes (NDC)2Issued by the FDA

Note:Payers require the submission of the 11-digit NDC on healthcare claim forms. Please use the 11-digit codes shown here.

59572-0720-12

COPY

100 mg capsules, bottle of 120 capsules

International Classification of Diseases, Tenth Revision, Clinical Modification Diagnosis Codes (ICD-10-CM)3

D47.4

COPY

Osteomyelofibrosis

D75.81

COPY

Myelofibrosis

INREBIC may be purchased through the distributors listed below.

Physician Offices

Authorized Distributor Phone Orders Fax Orders and Website
Cardinal Health Specialty
Pharmaceutical Distribution		 1-877-453-3972 https://specialtyonline.cardinalhealth.com
CuraScript Specialty Distribution 1-877-599-7748 https://www.curascriptsd.com
McKesson Specialty Health 1-800-482-6700
 https://mscs.mckesson.com
Oncology Supply 1-800-633-7555
 https://www.oncologysupply.com

For offices that prefer to use the services of a specialty pharmacy, specialty pharmacies can obtain INREBIC from the distributors listed above.

Hospitals and Infusion Centers

Authorized Distributor Phone Orders Fax Orders and Website
ASD Healthcare 1-800-746-6273
 Fax: 1-800-547-9413 https://www.asdhealthcare.com
Cardinal Health Specialty
Pharmaceutical Distribution		 1-866-677-4844
 Fax: 1-614-553-6301 https://orderexpress.cardinalhealth.com
McKesson Plasma and Biologics 1-877-625-2566
 Fax: 1-888-752-7626 https://connect.mckesson.com

Puerto Rico Hospitals and Clinics

Authorized Distributor Phone Orders Fax Orders and Website
Cardinal Puerto Rico (Borschow) 1-787-625-4200 https://orderexpress.cardinalhealth.com
Cesar Castillo Inc. 1-787-641-5242 (Hospitals)
1-787-641-5082 (Specialty Pharmacy)		 Fax: 1-787-999-1614
https://www.facilfarmaciacci.com

Above information is accurate as of 04/22.

The INREBIC distribution program includes extended payment terms to Bristol Myers Squibb authorized INREBIC distributors. Healthcare providers and institutions should contact their INREBIC distributor to understand specific payment terms that may be available to them from their distributor.

Please see U.S. Full Prescribing Information for INREBIC, including Boxed WARNING.

FDA Approval Letter as Posted by the FDA:

For the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF)
View Letter

Please see U.S. Full Prescribing Information for INREBIC, including Boxed WARNING.

Coding for INREBIC is dependent on the insurer and the care setting in which the drug will be administered. Oncology practices need to make coding decisions based on the diagnosis and treatment of each patient and the specific insurer requirements.

Please see U.S. Full Prescribing Information for INREBIC, including Boxed WARNING.

*Healthcare providers should code healthcare claims based upon the service that is rendered, the patient's medical record, the coding requirements of each health insurer, and best coding practices. Coding guidance provided under this heading does not provide a guarantee of reimbursement and should be considered together with all applicable coding guidance and standards. All of the coding information presented by this website is applicable to outpatient procedures only.

References:

  1. American Medical Association. 2020 HCPCS Level II. Professional ed. Chicago, IL: American Medical Association; 2020.
  2. INREBIC [package insert]. Princeton, NJ: Bristol-Myers Squibb Company.
  3. Centers for Medicare & Medicaid Services. ICD-10-CM tabular list of diseases and injuries. https://www.cms.gov/Medicare/Coding/ICD10/2020-ICD-10-CM. Accessed January 28, 2022.

The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.

Support Center icon
Support Center: 1-800-861-0048
8 am to 8 pm ET, Mon - Fri
Schedule a Call icon rtArrY
Schedule a call from a Patient Access SpecialistSchedule a Call >
Request a Visit icon
Request a visit from a BMS Access & Reimbursement ManagerRequest a Visit >
Schedule a Call > Request a Visit >
BMS Logo

2010-US-2100070 06/21

©2022 Bristol-Myers Squibb Company. Access Support is a registered trademark of Bristol-Myers Squibb Company. INREBIC® is a trademark of Impact Biomedicines, Inc.

Use of the information on this site is subject to the terms of our Legal Notice and Privacy Statement. The coding, coverage, and payment information contained within this website is current as of 04/22.

2010-US-2100137 04/22